Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Musculoskeletal  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Rheumatoid Arthritis Clinical Trials

A listing of Rheumatoid Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (393) clinical trials

Patients with rheumatoid arthritis can develop unpredictable worsening of their disease (flare) that is extraordinarily painful and limits ability to function. Flares are often preceded by early warnings of fatigue and flu-like symptoms. It is not known how long these early warning symptoms last or what causes them. It is ...

Phase N/A

Winthrop University Hospital Clinical Trials Center in conjunction with The Division of Rheumatology and The Arthritis and Rheumatic Disease Center is conducting a clinical research study on an investigational medication, for patient with dry mouth associated with SjÖgren’s Syndrome. This study will evaluate the safety and effectiveness of an investigational ...

Phase N/A

FINCH 1 is enrolling RA patients who have taken methotrexate (also known as MTX, TREXALL, or RASUVO) but have not yet tried a biologic treatment. Filgotinib (study drug) is an oral medication designed to reduce joint inflammation.

Phase

Rheumatoid Arthritis is a chronic immune/inflammatory disease characterized by persistent synovitis. If you have a diagnosis of rheumatoid arthritis, a clinical research study could be an option for you. New England Research is currently conducting a study to test the safety and effectiveness of the the drug Olokizumab in patients ...

Phase

Adults with Rheumatoid Arthritis with inadequate response to MTX may qualify to have Vectra DA guided treatment for 12 months.

Phase

Moderately to Severe active Rheumatoid Arthritis which have been inadequately controlled by Tumor Necrosis Factor Alpha (TNF-a) inhibitor therapy

Phase

Participation in this research study would last approximately 24 weeks and would include at least 11 visits to our office. Compensation up to $75 per visit may be provided for time and travel.

Phase

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate.

Phase